Blood-grouping reagents market in Hungary

Earlier Report Observations

Between 2018 and 2019, the Hungarian blood-grouping reagents market remained stable at around $9.8 million. This period was characterized by established regulatory frameworks, including Decree 19/2004 which set rules for reagent quality and distribution through the National Blood Supply Service, alongside requirements for reagent transparency and expiry date determination. In 2019, the emphasis on precise laboratory handling of reagents reinforced quality assurance standards within the market.

Market volume grew to $10.7 million in 2020 and surged to $14.6 million in 2021. The significant expansion in 2021 was concurrent with the broadening of laboratory services, such as SYNLAB Hungary offering blood-group determination and antibody screening, which increased testing accessibility and drove demand for reagents. The foundational clinical importance of AB0 and Rh systems, particularly in managing Rh incompatibility during pregnancy, sustained core demand for these diagnostic tools.

In the following years, market evolution continued with product innovation. The year 2022 saw the launch of home-use blood-grouping rapid tests, creating a new consumer segment and diversifying market offerings. By 2024, Hungary's industrial strategy for 2024-2030 explicitly prioritized the healthcare sector, including support for diagnostic reagent development, while the discovery of the new MAL blood-group system indicated ongoing research activity relevant to future reagent development.

Production blood-grouping reagents in Hungary

In value, 2017-2020, K $ US

Hungary's production of blood-grouping reagents grew for the second year in a row. In 2020, output reached 7 113 thousand US dollars, marking a 17.2% increase from the previous year. Over the period from 2017 to 2020, production rose by 3.3%, which translates to an average annual growth rate of 1.1%. The lowest production value was recorded in 2018 at 5 666 thousand US dollars, with the largest decline of 17.8% also occurring that year.

Annual dynamics of production in Hungary in value, 2017-2020, K $ US

Exports blood-grouping reagents from Hungary

Exports in kind, kg

Market performance showed significant fluctuations during this period. Export volumes varied 3.8 times from the low in 2018 to the high in 2020. In 2020, Hungary exported 1 708 kilograms of blood-grouping reagents, a substantial increase of 225.3% compared to the prior year. The minimum volume was recorded in 2018 at 455 kilograms, with the largest decline of 13.0% also occurring that year.

Annual dynamics of product's exports from Hungary in kind, 2017-2020, kg

From 2017 to 2020, Germany, Turkey, and Serbia were the main buyers of blood-grouping reagents from Hungary, accounting for 34.1%, 26.0%, and 12.7% of exports in kind, respectively. Together, these three countries represented 72.8% of total exports in kind.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Hungary in kind, 2017-2020

Exports in value, K $ US

Exports of blood-grouping reagents from Hungary declined for the second consecutive year. In 2020, exports amounted to 176 thousand US dollars, reflecting a significant reduction of 14.7% year-over-year. Over the 2017-2020 period, exports decreased by 10.7%, with a compound annual growth rate of -3.7%. The highest value was recorded in 2018 at 233 thousand US dollars, which also saw the largest increase of 18.3%.

Annual dynamics of product's exports from Hungary in value, 2017-2020, K $ US

From 2017 to 2020, Turkey, Switzerland, and India consistently remained the top destinations for Hungary's blood-grouping reagents exports in value terms, with shares of 49.4%, 17.4%, and 9.1%, respectively. Combined, these three countries accounted for 75.9% of total export value.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Hungary in value, 2017-2020

Imports blood-grouping reagents to Hungary

Imports in kind, kg

Hungary's imports of blood-grouping reagents declined for the third consecutive year. In 2020, Hungary imported a total of 3 738 kilograms of blood-grouping reagents, representing a significant decline of 17.8% compared to the previous year. Between 2017 and 2020, imports decreased by 42.7%, equating to an annualized rate of -17.0%.

Annual dynamics of product's imports to Hungary in kind, 2017-2020, kg

From 2017 to 2020, the leading sources for Hungary's imports of blood-grouping reagents in kind were Switzerland, the United Kingdom, and Spain, with shares of 30.4%, 23.3%, and 22.2%, respectively. Together, these three countries accounted for 75.9% of total imports in kind.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Hungary in kind, 2017-2020

Imports in value, K $ US

Hungary's imports of blood-grouping reagents declined for the third consecutive year. In 2020, imports totaled 3 738 thousand US dollars, down by 5.7% year-over-year. Over the 2017-2020 period, imports decreased by 15.6%, with a compound annual growth rate of -5.5%.

Annual dynamics of product's imports to Hungary in value, 2017-2020, K $ US

Throughout 2017 to 2020, Switzerland, Germany, and Spain remained the key partners for Hungary's imports of blood-grouping reagents in value terms, with shares of 35.4%, 27.4%, and 24.2%, respectively. Together, these three countries accounted for 87.0% of total import value.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Hungary in value, 2017-2020